Compare $ALT vs $ASMB | Chartloom

Compare

$ALT vs $ASMB

Altimmune Inc · Assembly Biosciences Inc

ALT

Altimmune Inc

ASMB

Assembly Biosciences Inc

Compare $ALT vs $ASMB

Comparing Altimmune Inc and Assembly Biosciences Inc

ALTAltimmune Inc

ASMBAssembly Biosciences Inc

ALTAltimmune Inc

Market cap

$508M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

55.0%

YTD performance

-25.6%

52W performance

-33.6%

FCF yield

-15.1%

ASMBAssembly Biosciences Inc

Market cap

$466M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

17.93x

Rev growth (TTM)

125.1%

YTD performance

-30.3%

52W performance

-7.7%

FCF yield

-8.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ALT

ASMB

Detailed metrics comparison

ALT

Altimmune Inc

ASMB

Assembly Biosciences Inc

Market Cap

ALT$508M

ASMB$466M

Enterprise Value

ALT$479M

ASMB$434M

Price

ALT$2.61

ASMB$23.53

P/E Ratio

ALTN/A

ASMBN/A

P/S Ratio

ALT16,373.12x

ASMB6.23x

EV/Sales

ALT15,461.31x

ASMB5.80x

EV/EBITDA

ALT0.00x

ASMB0.00x

P/B Ratio

ALT1.12x

ASMB1.50x

P/FCF Ratio

ALTN/A

ASMBN/A

EV/FCF

ALT-6.26x

ASMB-11.26x

PEG Ratio

ALTN/A

ASMBN/A

Forward P/E (NTM)

ALTN/A

ASMBN/A

Forward P/S (NTM)

ALTN/A

ASMB17.93x

Revenue (TTM)

ALT$31K

ASMB$75M

Revenue Growth (YoY)

ALT55.0%

ASMB125.1%

Forward Rev Growth

ALT217.1%

ASMB2.1%

Gross Margin (TTM)

ALT0.0%

ASMB0.0%

Operating Margin (TTM)

ALT0.0%

ASMB0.0%

EBITDA Margin (TTM)

ALT-322987.1%

ASMB-11.6%

Net Margin (TTM)

ALT-296000.0%

ASMB-0.1%

FCF Margin (TTM)

ALT-246974.2%

ASMB-51.5%

Net Income (TTM)

ALT$-92M

ASMB$-42K

FCF (TTM)

ALT$-77M

ASMB$-39M

EPS (TTM)

ALT-$0.49

ASMB-$0.00

ROE (TTM)

ALT-3141.0%

ASMB-2.0%

ROA (TTM)

ALT-2696.0%

ASMB-2.0%

ROIC (TTM)

ALT-2853.0%

ASMB-2.0%

Cash

ALT$63M

ASMB$32M

Debt

ALT$35M

ASMB$0

Net Cash/Debt

ALT$28M

ASMB$32M

Current Ratio (TTM)

ALT26.78x

ASMB13.99x

Quick Ratio (TTM)

ALT26.37x

ASMB13.70x

Debt/Equity (TTM)

ALT0.07x

ASMB0.00x

Debt/Assets (TTM)

ALT0.0%

ASMB0.0%

Interest Coverage (TTM)

ALTN/A

ASMBN/A

Net Debt/EBITDA (TTM)

ALT0.00x

ASMB0.00x

Beta

ALT0.06

ASMB1.21

52W Performance

ALT-33.6%

ASMB-7.7%

YTD Performance

ALT-25.6%

ASMB-30.3%

% from 52W High

ALT-59.5%

ASMB-40.7%

% from 52W Low

ALT2.4%

ASMB8.0%

Asset Turnover (TTM)

ALT0.00x

ASMB0.28x

FCF Yield (TTM)

ALT-15.1%

ASMB-8.3%

Earnings Yield (TTM)

ALT-18.1%

ASMB-0.0%

Dividend Yield (TTM)

ALTN/A

ASMBN/A

Rule of 40

ALT-246,919.2

ASMB73.6

EV/GP/RG

ALTN/A

ASMBN/A

Ticker research

View ALT research View ASMB research

Metric	ALT Altimmune Inc	ASMB Assembly Biosciences Inc
Market & Valuation
Market Cap	$508M	$466M
Enterprise Value	$479M	$434M
Price	$2.61	$23.53
P/E Ratio	N/A	N/A
P/S Ratio	16,373.12x	6.23x
EV/Sales	15,461.31x	5.80x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.12x	1.50x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.26x	-11.26x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	17.93x
Revenue & Growth
Revenue (TTM)	$31K	$75M
Revenue Growth (YoY)	55.0%	125.1%
Forward Rev Growth	217.1%	2.1%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-322987.1%	-11.6%
Net Margin (TTM)	-296000.0%	-0.1%
FCF Margin (TTM)	-246974.2%	-51.5%
Net Income (TTM)	$-92M	$-42K
FCF (TTM)	$-77M	$-39M
EPS (TTM)	-$0.49	-$0.00
ROE (TTM)	-3141.0%	-2.0%
ROA (TTM)	-2696.0%	-2.0%
ROIC (TTM)	-2853.0%	-2.0%
Financial Health
Cash	$63M	$32M
Debt	$35M	$0
Net Cash/Debt	$28M	$32M
Current Ratio (TTM)	26.78x	13.99x
Quick Ratio (TTM)	26.37x	13.70x
Debt/Equity (TTM)	0.07x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.06	1.21
52W Performance	-33.6%	-7.7%
YTD Performance	-25.6%	-30.3%
% from 52W High	-59.5%	-40.7%
% from 52W Low	2.4%	8.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.28x
FCF Yield (TTM)	-15.1%	-8.3%
Earnings Yield (TTM)	-18.1%	-0.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-246,919.2	73.6
EV/GP/RG	N/A	N/A
Ticker research	View ALT research	View ASMB research

Valuation

P/S Ratio

ASMB

6.23x

ALT

16,373.12x

EV/FCF

ASMB

-11.26x

ALT

-6.26x

Growth & revenue

Revenue Growth TTM

ASMB

125.1%

ALT

55.0%

Forward Revenue Growth

ALT

217.1%

ASMB

2.1%

Profitability & performance

Gross Margin

ALT

0.0%

ASMB

0.0%

ROE

ASMB

-2.0%

ALT

-3141.0%

FCF Yield %

ASMB

-8.3%

ALT

-15.1%

52-Week Performance

ASMB

-7.7%

ALT

-33.6%

Detailed metrics comparison

ALT

Altimmune Inc

ASMB

Assembly Biosciences Inc

Market Cap

ALT$508M

ASMB$466M

Enterprise Value

ALT$479M

ASMB$434M

Price

ALT$2.61

ASMB$23.53

P/E Ratio

ALTN/A

ASMBN/A

P/S Ratio

ALT16,373.12x

ASMB6.23x

EV/Sales

ALT15,461.31x

ASMB5.80x

EV/EBITDA

ALT0.00x

ASMB0.00x

P/B Ratio

ALT1.12x

ASMB1.50x

P/FCF Ratio

ALTN/A

ASMBN/A

EV/FCF

ALT-6.26x

ASMB-11.26x

PEG Ratio

ALTN/A

ASMBN/A

Forward P/E (NTM)

ALTN/A

ASMBN/A

Forward P/S (NTM)

ALTN/A

ASMB17.93x

Revenue (TTM)

ALT$31K

ASMB$75M

Revenue Growth (YoY)

ALT55.0%

ASMB125.1%

Forward Rev Growth

ALT217.1%

ASMB2.1%

Gross Margin (TTM)

ALT0.0%

ASMB0.0%

Operating Margin (TTM)

ALT0.0%

ASMB0.0%

EBITDA Margin (TTM)

ALT-322987.1%

ASMB-11.6%

Net Margin (TTM)

ALT-296000.0%

ASMB-0.1%

FCF Margin (TTM)

ALT-246974.2%

ASMB-51.5%

Net Income (TTM)

ALT$-92M

ASMB$-42K

FCF (TTM)

ALT$-77M

ASMB$-39M

EPS (TTM)

ALT-$0.49

ASMB-$0.00

ROE (TTM)

ALT-3141.0%

ASMB-2.0%

ROA (TTM)

ALT-2696.0%

ASMB-2.0%

ROIC (TTM)

ALT-2853.0%

ASMB-2.0%

Cash

ALT$63M

ASMB$32M

Debt

ALT$35M

ASMB$0

Net Cash/Debt

ALT$28M

ASMB$32M

Current Ratio (TTM)

ALT26.78x

ASMB13.99x

Quick Ratio (TTM)

ALT26.37x

ASMB13.70x

Debt/Equity (TTM)

ALT0.07x

ASMB0.00x

Debt/Assets (TTM)

ALT0.0%

ASMB0.0%

Interest Coverage (TTM)

ALTN/A

ASMBN/A

Net Debt/EBITDA (TTM)

ALT0.00x

ASMB0.00x

Beta

ALT0.06

ASMB1.21

52W Performance

ALT-33.6%

ASMB-7.7%

YTD Performance

ALT-25.6%

ASMB-30.3%

% from 52W High

ALT-59.5%

ASMB-40.7%

% from 52W Low

ALT2.4%

ASMB8.0%

Asset Turnover (TTM)

ALT0.00x

ASMB0.28x

FCF Yield (TTM)

ALT-15.1%

ASMB-8.3%

Earnings Yield (TTM)

ALT-18.1%

ASMB-0.0%

Dividend Yield (TTM)

ALTN/A

ASMBN/A

Rule of 40

ALT-246,919.2

ASMB73.6

EV/GP/RG

ALTN/A

ASMBN/A

Ticker research

View ALT research View ASMB research

Metric	ALT Altimmune Inc	ASMB Assembly Biosciences Inc
Market & Valuation
Market Cap	$508M	$466M
Enterprise Value	$479M	$434M
Price	$2.61	$23.53
P/E Ratio	N/A	N/A
P/S Ratio	16,373.12x	6.23x
EV/Sales	15,461.31x	5.80x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.12x	1.50x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.26x	-11.26x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	17.93x
Revenue & Growth
Revenue (TTM)	$31K	$75M
Revenue Growth (YoY)	55.0%	125.1%
Forward Rev Growth	217.1%	2.1%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-322987.1%	-11.6%
Net Margin (TTM)	-296000.0%	-0.1%
FCF Margin (TTM)	-246974.2%	-51.5%
Net Income (TTM)	$-92M	$-42K
FCF (TTM)	$-77M	$-39M
EPS (TTM)	-$0.49	-$0.00
ROE (TTM)	-3141.0%	-2.0%
ROA (TTM)	-2696.0%	-2.0%
ROIC (TTM)	-2853.0%	-2.0%
Financial Health
Cash	$63M	$32M
Debt	$35M	$0
Net Cash/Debt	$28M	$32M
Current Ratio (TTM)	26.78x	13.99x
Quick Ratio (TTM)	26.37x	13.70x
Debt/Equity (TTM)	0.07x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.06	1.21
52W Performance	-33.6%	-7.7%
YTD Performance	-25.6%	-30.3%
% from 52W High	-59.5%	-40.7%
% from 52W Low	2.4%	8.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.28x
FCF Yield (TTM)	-15.1%	-8.3%
Earnings Yield (TTM)	-18.1%	-0.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-246,919.2	73.6
EV/GP/RG	N/A	N/A
Ticker research	View ALT research	View ASMB research